High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma
To determine safety and toxicity of a regimen of high dose chemotherapy with allogeneic
peripheral blood progenitor cell transplantation; determine the efficacy of the procedure by
following clinical outcomes and quality of life measures; and evaluate graft versus host
disease incidence and severity with regimen.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|Stanford University School of Medicine||Stanford, California 94305-5317|